Thank you for that question. I'm a proud alumnus of the University of Waterloo, so I understand it.
That is a big problem. I think a lot of it is, frankly, due to a lack of risk capital in the country here.
Also, as I stated in my proposal, in the case of biotechnology, where other areas have flourished is where there has been access to non-dilutive risk capital that you can get access to before the private sector will be ready to invest. That gap is, I think, one of the biggest challenges we're facing here in Canada, and we have to find a way to get through it.